Calcium channel News (3 articles)
Novartis gains positive CHMP opinion for Rasilamlo(TM), a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Rasilamlo combines in a single pill the only approved direct renin inhibitor, Rasilez, with the widely used calcium channel blocker amlodipine Data from over 5,000 mild-to-severe high blood pressure patients showed Rasilamlo significantly reduced blood pressure compared...
Published on 18 February 2011, 10:29
We have launched our peer- reviewed, Open-access journal: Insciences Journal